The latest biotech news

News and Trends 26 Mar 2015

With €200 Million, Cellectis is on its way to make the Biggest French Biotech IPO ever

Exactly one month ago, the article "Cellectis is preparing its IPO in the U.S" explained Cellectis prepared an IPO to be listed on the NASDAQ. Yesterday, the company announced the…

March 26, 2015 - 2 minutesmins - By Joachim Eeckhout

metamorphosis biopharmceutical innovation bio europe spring 2015

News and Trends 26 Mar 2015

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

Innovation can occur in many different ways, and biopharmaceutical innovation is no exception. The pipelines of big Pharmas have fewer candidates, R&D costs are skyrocketing, internal research programs tend to shrink…

March 26, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 26 Mar 2015

Apceth Initiates Phase II for its pioneering Engineered Cell Therapy to treat Gastrointestinal Cancer

After successfully complete phase I clinical study, apceth initiates the Phase II of world’s first genetically-engineered cell therapy. The ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered…

March 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Mar 2015

The Genomic Portrait of Iceland

A package of four landmark papers were published yesterday in the online edition of Nature Genetics. The research, written by a team of deCODE scientists, was built on whole-genome sequence data…

March 26, 2015 - 4 minutesmins - By Lourdes Riquelme

News and Trends 25 Mar 2015

Epigenomics’ proColon, the non-invasive blood-based test for colorectal cancer

Epigenomics, the German-American cancer molecular diagnostics company, completed the enrollment for its ADMIT trial (AD herence to Minimally Invasive Testing) for Epi proColon, its non-invasive blood-based test for colorectal cancer (CRC)…

March 25, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 25 Mar 2015

The Institut Pasteur and IntegraGen, allies to Strengthen High-Throughput Sequencing in Microbiology

IntegraGen and the Institut Pasteur signed an agreement for high-throughput sequencing in the field of Microbiology. IntegraGen will be responsible for the technical and operational implementation of high-throughput sequencing activities…

March 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 24 Mar 2015

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Rigontec has raised €4.8M in the second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture…

March 24, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 23 Mar 2015

Life Sciences have a new big player: Joint Polish Investment Fund Management

Poland’s first Institutional Venture Capital Fund dedicated to Life Sciences announced today the first closing of its new venture capital fund at €38.5M. Joint Polish Investment Fund Management (JPIF), headed…

March 23, 2015 - 3 minutesmins - By Lourdes Riquelme

AOP Orphan Pharmaceuticals Confluence Pharmaceuticals Fragile X

News and Trends 23 Mar 2015

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

AOP Orphan Pharmaceuticals and Confluence Pharmaceuticals, signed today a definitive agreement to co-develop and market Confluence’s lead asset, a product for the treatment of Fragile X Syndrome in Europe and…

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 23 Mar 2015

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

University of Copenhagen released a vaccine candidate against the form of malaria that strikes pregnant women, for testing in humans. The vaccine candidate contains a malaria antigen made with ExpreS2ion…

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 21 Mar 2015

#BioFigures: 12 Key French Players launch New Immunotechnology Reference Center MI-mabs

WHO? MI-mAbs ("MI" for Marseille Immunopole and "mAbs" for monoclonal antibody) is a new immunotechnology center headed by Prof. Francois Romagne, located at the heart of the Marseille-Luminy Scientific and…

March 21, 2015 - 2 minutesmins - By Marie Godar

News and Trends 20 Mar 2015

Optibrium introduces the lastest version of StarDrop

Cambridge-based Optibrium has launched of version 6.1 of its StarDrop platform to guide researchers in the design of high quality compounds in drug discovery, agrochemicals and other chemistry fields. The…

March 20, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 20 Mar 2015

Let’s Focus on Calypso Biotech, a New Promising Startup that Concentrates on Niche Gastro-intestinal Diseases

Last week, I was in Bio Spring Europe and I met Alain Vicari, Calypso Biotech’s CEO: What is Calypso Biotech? Calypso Biotech discovers and develops antibody therapies for indications in…

March 20, 2015 - 3 minutesmins - By Julie Lellouche

microbiome microbiomics seventure partners

News and Trends 19 Mar 2015

The World’s First €100M Microbiome-focused Venture Fund opened in France

Microbiomics is one of the next big trends in the Biotech industry. Using bacteria present in our guts to cure people has shown more and more potential. The VC industry is…

March 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 19 Mar 2015

Syngenta corn trait expansion further continues thanks the Vietnamese approval

A few days ago, Syngenta announced that the Vietnamese Ministry of Natural Resources and Environment has approved its Bt11 x GA21 double stack corn seed for commercial cultivation in the…

March 19, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 18 Mar 2015

Novartis’ Jakavi receives European Commission approval

Novartis received the approval from the European Commission for Jakavi (ruxolitinib) for the treatment of adult patients with Polycythemia Vera (PV) who are resistant to or intolerant of hydroxyurea. Jakavi…

March 18, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 Mar 2015

Valneva penetrates Chinese Market thanks to a license agreement

A few months ago, the article "An Anglo-French Partnership To Cure Hepatitis B" related Valneva partnerships with Immune Targeting Systems. Today Valneva, a leading pure play vaccines biotech company is…

March 18, 2015 - 2 minutesmins - By Joachim Eeckhout

New oncology neoliquid neoplus cancer diagnosis

News and Trends 17 Mar 2015

New Oncology finances its Genetic Test for Cancer Diagnosis

New Oncology completed a financing round to prepare the market launch of NEOliquid, a non-invasive blood test that identifies therapeutically actionable genome alterations in the circulating free tumor DNA (ctDNA)…

March 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Mar 2015

MISSION Appoints Paul Wallace as Chief Business Officer

Mission Therapeutics, a company focused on the discovery and development of modulators of the deubiquitylating (DUB) enzyme family for the treatment of cancer and other diseases, appointed Paul Wallace as…

March 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Mar 2015

Against Being Against GMOs: The Golden Rice Story

At the Zurich Life Science Day, I had the pleasure of hearing the keynote speaker, Professor Ingo Potrykus, Professor Emeritus of Plant Sciences at the Institute of Plant Sciences at…

March 16, 2015 - 6 minutesmins - By Joachim Eeckhout

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Changing the Partner Discovery Game with Connect for Biotech

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!